Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3693169019 | Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3693170018 | Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 milligram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Is a | Product containing dorzolamide and timolol (medicinal product) | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has active ingredient | Timolol (substance) | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has active ingredient | Dorzolamide (substance) | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has active ingredient | Dorzolamide hydrochloride | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has active ingredient | Timolol maleate | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has manufactured dose form | Eye drops | true | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Is a | Product manufactured as ocular dose form (product) | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Is a | Ophthalmic sulfonamide preparation | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has active ingredient | Carbonic anhydrase inhibitor | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Is a | Product containing timolol in ophthalmic dosage form | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has precise active ingredient | Timolol maleate | true | Inferred relationship | Some | 1 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has basis of strength substance (attribute) | Dorzolamide (substance) | true | Inferred relationship | Some | 2 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength numerator value | 5 | false | Inferred relationship | Some | 1 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength numerator value | 20 | false | Inferred relationship | Some | 2 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has precise active ingredient | Dorzolamide hydrochloride | true | Inferred relationship | Some | 2 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has basis of strength substance (attribute) | Timolol (substance) | true | Inferred relationship | Some | 1 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Plays role | Antiglaucoma therapeutic role | false | Inferred relationship | Some | ||
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Is a | Dorzolamide and timolol only product in ocular dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets